CORONAVIRUS

Moonshot is the spanner in the Covid-19 works the country needs

Antivirals like molnupiravir are the third line in our long-term fight against coronavirus

The Covid Moonshot project is working towards a cheap, plentiful and off-patent antiviral
The Covid Moonshot project is working towards a cheap, plentiful and off-patent antiviral
Tom Whipple
The Times

At about the time the world was focusing on the first vaccine trials, in Oxfordshire an intense beam of light was focusing on something else.

Caught in its glare, ten billion times brighter than the sun’s, was a pinhead. On that pinhead was a crystal. The crystal contained an enzyme of coronavirus, along with something else, and in that lay, perhaps, the clue to making Covid-19 something we can live with.

In the blinding light scientists could see that this enzyme, which is crucial to viral reproduction, was locked tightly to its nemesis, a molecular kryptonite.

For 18 months the world has looked to the vaccine race for salvation but vaccines were never going to be enough. A vaccine can prevent coronavirus. What has taken